Search research articles
Contact Us
Filters
Showing results (351-360 of 362) with videos related to
Page
of 37
Sort By:
The Lancet. Oncology
|
June 17, 2020
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Marina Chiara Garassino, Jennifer G Whisenant, Li-Ching Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 27, 2016
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial
Solange Peters, Rolf A Stahel, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 6, 2017
Scientific Advances in Thoracic Oncology 2016
Ross A Soo, Emily C A Stone, K Michael Cummings, et al.
Cancer Discovery
|
July 24, 2020
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Donna R Rivera, Solange Peters, Orestis A Panagiotou, et al.
JCO Clinical Cancer Informatics
|
May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
Rebecca J Lee, Oskar Wysocki, Cong Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 5, 2022
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
Jennifer G Whisenant, Javier Baena, Alessio Cortellini, et al.
Cancers
|
August 26, 2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Oskar Wysocki, Cong Zhou, Jacobo Rogado, et al.
Lancet (London, England)
|
June 1, 2020
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al.
Journal for Immunotherapy of Cancer
|
February 4, 2025
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry
Alessio Cortellini, Valentina Santo, Leonardo Brunetti, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 362) with videos related to
Sort By:
Page
of 37
The Lancet. Oncology
|
June 17, 2020
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Marina Chiara Garassino, Jennifer G Whisenant, Li-Ching Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 27, 2016
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial
Solange Peters, Rolf A Stahel, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 6, 2017
Scientific Advances in Thoracic Oncology 2016
Ross A Soo, Emily C A Stone, K Michael Cummings, et al.
Cancer Discovery
|
July 24, 2020
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Donna R Rivera, Solange Peters, Orestis A Panagiotou, et al.
JCO Clinical Cancer Informatics
|
May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
Rebecca J Lee, Oskar Wysocki, Cong Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 5, 2022
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
Jennifer G Whisenant, Javier Baena, Alessio Cortellini, et al.
Cancers
|
August 26, 2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Oskar Wysocki, Cong Zhou, Jacobo Rogado, et al.
Lancet (London, England)
|
June 1, 2020
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al.
Journal for Immunotherapy of Cancer
|
February 4, 2025
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry
Alessio Cortellini, Valentina Santo, Leonardo Brunetti, et al.
Page
of 37